Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer

Area of Science:

• Oncology
• Biomedical Engineering
• Photochemistry

Background:

• Cancer remains a leading global cause of death, necessitating novel therapeutic strategies.
• Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options and poor survival rates.
• Photodynamic therapy (PDT) utilizes photosensitizers to target and destroy cancer cells, offering a promising avenue for treatment.

Purpose of the Study:

• To review recent advancements in chlorin-based photoactive molecules for targeted TNBC therapy.
• To explore the potential of PDT, alone or in combination, as a safe and effective treatment for TNBC.

Main Methods:

• Literature review focusing on chlorin derivatives and their application in TNBC treatment.
• Analysis of studies investigating photosensitizer properties, targeting capabilities, and therapeutic efficacy.
• Examination of PDT's role in combination therapies for enhanced outcomes.

Main Results:

• Chlorin-based photosensitizers demonstrate potential for specific targeting of TNBC cells.
• PDT exhibits promise as a standalone therapy and when combined with chemotherapy or photothermal therapy.
• Optimized photosensitizers with absorption in the therapeutic window are crucial for PDT efficacy.

Conclusions:

• Chlorin-based photoactive molecules represent a significant development in targeted TNBC therapy.
• Photodynamic therapy offers a safe and effective approach, particularly when integrated with other treatment modalities.
• Further research into these agents could lead to improved survival rates for TNBC patients.